Josephine Egan from Kensington, MD, age 60

Medicine Doctors

Dr. Josephine M Egan, Baltimore MD - MD (Doctor of Medicine)

view source

Specialties:

Endocrinology, Diabetes & Metabolism
Endocrinology & Metabolism

Address:

3001 S Hanover St, Baltimore, MD 21225
4105588381 (Phone), 4103503979 (Fax)

251 Bayview Blvd Suite 100, Baltimore, MD 21224

Certifications:

Diabetes, Metabolism & Endocrinology, 1989
Internal Medicine, 1987

Awards:

Healthgrades Honor Roll

Languages:

English

Hospitals:

3001 S Hanover St, Baltimore, MD 21225

251 Bayview Blvd Suite 100, Baltimore, MD 21224

Medstar Harbor Hospital
3001 South Hanover Street, Baltimore, MD 21225

Education:

Medical School
University College of Cork / National University of Ireland
Medical School
Baylor College Of Medicine
Medical School
Regl Hosp

Josephine M Egan, Rockville MD

view source

Specialties:

Physical Therapy

Address:

3202 Tower Oaks Blvd Suite 280, Rockville, MD 20852
3012317800 (Phone)

Languages:

English

Josephine Mary Egan

view source

Specialties:

Internal Medicine
Endocrinology and Metabolism
Endocrinology, Diabetes & Metabolism

Education:

University College Galway (1978)

Josephine M Egan, Baltimore MD

view source

Specialties:

Endocrinologist

Address:

5600 Nathan Shock Dr, Baltimore, MD 21224
3001 S Hanover St, Brooklyn, MD 21225

Education:

National University of Ireland - Doctor of Medicine
Baylor Clinic & Hospital - Fellowship - Pharmacology
Baylor Clinic & Hospital - Residency - Internal Medicine
University College Hospital Galway - NUI - Residency - Internal Medicine
University College Hospital Galway - NUI - Residency - Family Medicine

Board certifications:

American Board of Internal Medicine Certification in Internal Medicine
American Board of Internal Medicine Sub-certificate in Endocrinology and Metabolism (Internal Medicine)

Josephine Mary Egan, Rockville MD

view source

Specialties:

Physical Therapist

Address:

3202 Tower Oaks Blvd, Rockville, MD 20852

Name / Title

Company / Classification

Phones & Addresses

Josephine Mary Egan

Josephine Egan MD
Internist

5600 Nathan Shock Dr, Baltimore, MD 21224
4105588185

Us Patents

Uses Of Notch Receptors, Notch Ligands, And Notch Modulators In Methods Related To Metabolic Diseases
view source
US Patent:

7888116, Feb 15, 2011
Filed:

Jul 22, 2005
Appl. No.:

11/658189
Inventors:

Josephine M. Egan - Baltimore MD, US
Máire E. Doyle - Gainesville FL, US
Assignee:

The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:

C12N 5/00
US Classification:

435325
Abstract:

Disclosed are methods for identifying and isolating a precursor cell. Also, disclosed are methods of increasing insulin synthesis from a pancreatic B-cell. Further, disclosed are methods of improving pancreatic B-cell function. Still further, disclosed are methods of preventing or delaying the onset of a metabolic disease, methods of treating or preventing a metabolic disease in a subject, and to compositions for treating or preventing a metabolic disease in a subject in need of such treatment or prevention.

Taste Signaling In Gastrointestinal Cells
view source
US Patent:

20050244810, Nov 3, 2005
Filed:

Sep 24, 2004
Appl. No.:

10/949751
Inventors:

Josephine Egan - Baltimore MD, US
Stephen Gravine - Rutherford NJ, US
Robert Margolskee - Upper Montclair NJ, US
Richard McGregor - Rutherford NJ, US
Lenore Snyder - New York NY, US
Michael Theodorakis - Baltimore MD, US
International Classification:

C12Q001/00
US Classification:

435004000
Abstract:

Disclosed are materials and methods relevant to taste transduction. Also disclosed are human gastrointestinal cells that comprise or are capable expressing endogenous taste signaling proteins. Also disclosed are human gastrointestinal cells that comprise or are capable of expressing endogenous taste signaling proteins as well as hormones, neurotransmitters or soluble mediators of the gastrointestinal tract that are involved in or affect metabolism, digestion and appetite. Also disclosed are the uses of these human cells or their membranes to study how compounds affect taste transduction and/or metabolism, digestion and appetite, including effects on satiety, emesis and diabetes.

Differentiation Of Non-Insulin Producing Cells Into Insulin Producing Cells By Glp-1 Or Exendin-4 And Uses Thereof
view source
US Patent:

20070041951, Feb 22, 2007
Filed:

Apr 7, 2006
Appl. No.:

11/400715
Inventors:

Josephine Egan - Baltimore MD, US
Riccardo Perfetti - Washington DC, US
Antonino Passaniti - White Hall MD, US
Nigel Greig - Silver Spring MD, US
Harold Holloway - Middle River MD, US
Joel Habener - Newton Centre MA, US
Doris Stoffers - Moorestown NJ, US
International Classification:

A61K 35/39
C12N 5/08
US Classification:

424093700, 435366000, 435325000
Abstract:

The present invention relates to a population of insulin producing cells made by a process comprising contacting non-insulin producing cells with a growth factor selected from the group consisting of GLP-1 or Exendin-4, growth factors having amino acid sequences substantially homologous to GLP-1 or Exendin-4, and fragments thereof. The present invention also relates to methods of differentiating non-insulin producing cells into insulin producing cells and of enriching a population of cells for insulin-producing cells. The present invention also relates to methods of treating diabetes.

Differentiation Of Non-Insulin Producing Cells Into Insulin Producing Cells By Glp-1 Or Exendin-4 And Uses Thereof
view source
US Patent:

7056734, Jun 6, 2006
Filed:

Aug 10, 1999
Appl. No.:

09/762538
Inventors:

Josephine Egan - Baltimore MD, US
Riccardo Perfetti - Washington DC, US
Antonino Passaniti - White Hall MD, US
Nigel Greig - Silver Spring MD, US
Harold Holloway - Middle River MD, US
Joel Habener - Newton Centre MA, US
Doris Stoffers - Moorestown NJ, US
Assignee:

The United States of America as represented by the Department of Health and Human Services, NIH - Washington DC
International Classification:

C12N 5/00
US Classification:

435325, 530308
Abstract:

The present invention relates to a population of insulin producing cells made by a process comprising contacting non-insulin producing cells with a growth factor selected from the group consisting of GLP-1 or Exendin-4, growth factors having amino acid sequences substantially homologous to GLP-1 or Exendin-4, and fragmets thereof. The present invention also relates to methods of differentiating non-insulin producing cells into insulin producing cells and of enriching a population of cells for insulin-producing cells. The present invention also relates to methods of treating diabetes.

Glp-1, Exendin-4, Peptide Analogs And Uses Thereof
view source
US Patent:

20150072930, Mar 12, 2015
Filed:

Aug 27, 2014
Appl. No.:

14/470528
Inventors:

- Rockville MD, US
Josephine M. Egan - Baltimore MD, US
Maire Doyle - Baltimore MD, US
Harold W. Holloway - Middle River MD, US
Tracy Perry - Baltimore MD, US
International Classification:

C07K 14/575
US Classification:

514 67, 514 117, 514 97
Abstract:

The invention relates to novel polypeptide analogs of GLP-1 and exendin-4. The polypeptide, in a preferred embodiment, is insulinotropic and long-acting. Preferably, the polypeptide's insulinotropic effect is comparable to or exceeds the effect of an equimolar amount of GLP-1 or exendin-4. The invention also relates to a method of treating a subject with diabetes, comprising administering to the subject the polypeptide of the invention in an amount that has an insulinotropic effect. The invention also relates to methods of using GLP-1, exendin-4, and polypeptide analogs thereof for neuroprotective and neurotrophic effects.